Manageable Early Toxicity of Cetuximab Concurrent with Radical Radiotherapy for Locally Advanced Head and Neck Cancer

被引:1
作者
Wieczorek, A. [1 ]
Hamid, A. [1 ]
O'Toole, L. [1 ]
机构
[1] Queens Ctr Oncol, Cottingham, E Riding York, England
关键词
D O I
10.1016/j.clon.2011.03.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:496 / 496
页数:1
相关论文
共 5 条
[1]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[2]   Cetuximab is effective, but more toxic than reported in the bonner trial [J].
Lord, H. K. ;
Junor, E. ;
Ironside, J. .
CLINICAL ONCOLOGY, 2008, 20 (01) :96-96
[3]   Radiochemotherapy in Locally Advanced Squamous Cell Carcinomas of the Head and Neck [J].
Matzinger, O. ;
Zouhair, A. ;
Mirimanoff, R. O. ;
Ozsahin, M. .
CLINICAL ONCOLOGY, 2009, 21 (07) :525-531
[4]  
*NIH CLIN EX, TECHN APPR GUID 145
[5]   Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer [J].
Pryor, David I. ;
Porceddu, Sandro V. ;
Burmeister, Bryan H. ;
Guminski, Alex ;
Thomson, Damien B. ;
Shepherdson, Kristine ;
Poulsen, Michael .
RADIOTHERAPY AND ONCOLOGY, 2009, 90 (02) :172-176